Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia

NCT02481791 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Children
Heart Diseases
Anaesthesia
Magnetic Resonance Imaging

Interventions

DRUG: Remifentanil and/or propofol
DRUG: Remifentanil and/or propofol
DRUG: propofol

Sponsor

Alder Hey Children's NHS Foundation Trust